Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

The current C$37.25 price target for Boralex is now closely aligned with the proposed take private offer, with the CA$36.88 fair value estimate held steady in the background. That closer link to the Brookfield Renewables proposal reflects how analysts are fine tuning their work around the deal outcome. Bullish voices are leaning on the offer as an anchor, while more cautious views highlight reduced potential upside beyond the transaction. As you read on, you will see how to track this evolving narrative and what it might mean for your own view on the stock.

Stay updated as the Fair Value for Boralex shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Boralex.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

• RBC Capital and Scotiabank have both issued research that includes higher price targets for Boralex, signaling support for the valuation implied by the proposed Brookfield Renewables transaction.

• The alignment of targets from multiple firms around the current C$37.25 level suggests analysts see the take private offer as a reasonable reference point for the stock's value.

🐻 Bearish Takeaways

• Raymond James downgraded Boralex to Market Perform from Outperform and set a C$37.25 price target, indicating limited expected upside beyond the proposed deal price.

• TD Securities also moved to a more cautious stance in March, which adds to the sense that, for now, execution and growth optionality beyond the transaction are not front and center in many models.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!

We've flagged 2 risks for Boralex. See which could impact your investment.

What's in the News

• Boralex shareholders approved a statutory plan of arrangement on June 4, 2026, for all Class A common shares to be acquired by BIF Thunder Holdings Inc. at $37.25 in cash per share.

• The transaction values about 85% of Boralex at roughly $3.3 billion, under a definitive agreement signed on March 25, 2026. The agreement also includes a $115 million termination fee and a $172 million reverse termination fee under certain circumstances.

• Following completion of the arrangement, Brookfield and Caisse de dépôt et placement du Québec intend to have Boralex shares delisted from the Toronto Stock Exchange and to apply for Boralex to cease to be a reporting issuer.

• Before the deal was announced, Boralex had formed a special committee to review options after media reports about a potential process. The Board later unanimously recommended that shareholders approve the transaction.